Article

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network Analysis

2020-03-30

Abstract excerpt

COVID-19 (2019-nCoV) is a pandemic disease with an estimated mortality rate of 3.4% (estimated by the WHO as of March 3, 2020). Until now there is no antiviral drug and vaccine for COVID-19. The current overwhelming situation by COVID-19 patients in hospitals is likely to increase in the next few months. About 15 percent of patients with serious disease in COVID-19 require immediate health services. Rather than wa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d773709c-bef4-5250-b264-03b8f2930631
DOI: 10.20944/preprints202003.0440.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisDOI 10.20944/preprints202003.0440.v1Read

Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysisSemantic proximity Read

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read

Modeling COVID-19 disease biology to identify drug treatment candidatesSemantic proximity Read

Bioinformatic approaches towards identification of potential repurposable drugs for COVID-19Semantic proximity Read

Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity Read

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read

Transcriptome and SARS-CoV-2 biological network directed analysis for better therapeutic developmentSemantic proximity Read

Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19Semantic proximity Read

Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approachesSemantic proximity Read

Five Critical Genes Related to Seven COVID-19 Subtypes: A Data Science DiscoverySemantic proximity Read

Between viral targets and differentially expressed genes in COVID-19: the sweet spot for therapeutic intervention.Semantic proximity Read